|
⚲
|
| Keyboard |
| van Dijken Eeuwijk Monique
✚
|
|
|---|---|
| CIK # | 0001801607 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001801607] | |
| 4 | [0001801607] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Core Laboratories N V | |
| van Dijken Eeuwijk Monique |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Core Laboratories N V CLB
Common Shares
|
2023-04-01 | Option exercise | 5,485 | $0.00 | |
|
Core Laboratories N V CLB
Restricted Shares · derivative
|
2023-04-01 | Option exercise | 5,485 | $0.00 | |
|
Core Laboratories N V CLB
Common Shares
|
2022-04-01 | Option exercise | 4,307 | $0.00 | |
|
Core Laboratories N V CLB
Restricted Shares · derivative
|
2022-04-01 | Grant | 5,485 | $0.00 | |
|
Core Laboratories N V CLB
Restricted Shares · derivative
|
2022-04-01 | Option exercise | 4,307 | $0.00 | |
|
Core Laboratories N V CLB
Common Shares
|
2021-04-01 | Tax withheld | 7,181 | $30.10 | 216,148 |
|
Core Laboratories N V CLB
Common Shares
|
2021-04-01 | Option exercise | 14,507 | $0.00 | |
|
Core Laboratories N V CLB
Restricted Shares · derivative
|
2021-04-01 | Option exercise | 14,507 | $0.00 | |
|
Core Laboratories N V CLB
Restricted Shares · derivative
|
2021-04-01 | Grant | 4,307 | $0.00 | |
|
Core Laboratories N V CLB
Restricted Shares · derivative
|
2020-05-20 | Grant | 14,507 | $0.00 |